Erytech Pharma SA operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Erytech Pharma SA with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £2.65 million [US$3.65 million]
of which 54%
Nuevolution AB (publ)
(21.31 million Swedish Kronor [US$2.65 million]
Co Don AG
based in Germany
(5.60 million Euro [US$6.86 million]
of which 100%
was Product sales).